Patents by Inventor Mohammad Dastjerdi

Mohammad Dastjerdi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for reducing corneal nerves damage, corneal lymphangiogenesis or immunity to corneal antigens in dry-eye associated ocular surface diseases by IL-1Ra
    Patent number: 10117906
    Abstract: The invention provides methods and compositions for minimizing, preventing, or treating damage to corneal nerves by administering to a subject with such damage or at risk of exposure to such damage a composition which blocks an activity of an IL-1 cytokine and/or an IL-17 cytokine.
    Type: Grant
    Filed: January 11, 2010
    Date of Patent: November 6, 2018
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Reza Dana, Mohammad Dastjerdi, Sunil Chauhan
  • Method for inhibiting or reducing dry eye disease by IL-1Ra
    Patent number: 10105441
    Abstract: The present invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-1 and methods for using this composition to treat inflammatory disease of ocular and adnexal tissues by topical administration. The present invention also discloses devices for delivering this composition to target tissues.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: October 23, 2018
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Reza Dana, Mohammad Dastjerdi
  • Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal Tissues
    Publication number: 20130273065
    Abstract: The present invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-1 and methods for using this composition to treat inflammatory disease of ocular and adnexal tissues by topical administration. The present invention also discloses devices for delivering this composition to target tissues.
    Type: Application
    Filed: March 12, 2013
    Publication date: October 17, 2013
    Inventors: Reza Dana, Mohammad Dastjerdi
  • Therapeutic Compositions for Treatment of Corneal Disorders
    Publication number: 20120014970
    Abstract: The invention provides methods and compositions for minimizing, preventing, or treating damage to corneal nerves by administering to a subject with such damage or at risk of exposure to such damage a composition which blocks an activity of an IL-1 cytokine and/or an IL-17 cytokine.
    Type: Application
    Filed: July 14, 2011
    Publication date: January 19, 2012
    Inventors: Reza Dana, Mohammad Dastjerdi, Sunil Chauhan
  • THERAPEUTIC COMPOSITIONS FOR TREATMENT OF INFLAMMATION OF OCULAR AND ADNEXAL TISSUES
    Publication number: 20100203103
    Abstract: The present invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-1 and methods for using this composition to treat inflammatory disease of ocular and adnexal tissues by topical administration. The present invention also discloses devices for delivering this composition to target tissues.
    Type: Application
    Filed: August 15, 2008
    Publication date: August 12, 2010
    Inventors: Reza Dana, Mohammad Dastjerdi
  • Therapeutic Compositions for Treatment of Corneal Disorders
    Publication number: 20100183587
    Abstract: The invention provides methods and compositions for minimizing, preventing, or treating damage to corneal nerves by administering to a subject with such damage or at risk of exposure to such damage a composition which blocks an activity of an IL-1 cytokine and/or an IL-17 cytokine.
    Type: Application
    Filed: January 11, 2010
    Publication date: July 22, 2010
    Applicant: Schepens Eye Research Institute
    Inventors: Reza Dana, Mohammad Dastjerdi, Sunil Chauhan